EGLN2 and breast carcinoma: Moreover, PHD1 regulation of cyclin D1 has further been demonstrated in breast cancer cells [69], whereupon inactivation of the Egln2 (Phd1) gene, cyclin D1 levels, and mammary gland cell proliferation decreased.